Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder.

Autor: Freet CS; Department of Psychiatry and Behavioral Health, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Evans B; Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Brick TR; Department of Human Development and Family Studies, The Pennsylvania State University, University Park, PA, USA.; Institute for Computational and Data Sciences, The Pennsylvania State University, University Park, PA, USA., Deneke E; Fran and Doug Tieman Center for Research, Caron Treatment Centers, Wernersville, PA, USA., Wasserman EJ; Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Ballard SM; Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Stankoski DM; Fran and Doug Tieman Center for Research, Caron Treatment Centers, Wernersville, PA, USA., Kong L; Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Raja-Khan N; Department of Psychiatry and Behavioral Health, The Pennsylvania State University College of Medicine, Hershey, PA, USA.; Department of Medicine, The Pennsylvania State University College of Medicine, Hershey, PA, USA.; Department of Obstetrics & Gynecology, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Nyland JE; Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Arnold AC; Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Krishnamurthy VB; Department of Medicine and Psychiatry, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Fernandez-Mendoza J; Department of Psychiatry and Behavioral Health, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Cleveland HH; Department of Human Development and Family Studies, The Pennsylvania State University, University Park, PA, USA., Scioli AD; Fran and Doug Tieman Center for Research, Caron Treatment Centers, Wernersville, PA, USA., Molchanow A; Synergy Pharmacy Services LLC, Norristown, PA, USA., Messner AE; Synergy Pharmacy Services LLC, Norristown, PA, USA., Ayaz H; School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA., Grigson PS; Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Bunce SC; Department of Psychiatry and Behavioral Health, The Pennsylvania State University College of Medicine, Hershey, PA, USA. sbunce@pennstatehealth.psu.edu.; Penn State University College of Medicine, Milton S. Hershey Medical Center, H073, 500 University Drive, Hershey, PA, 17033-0850, USA. sbunce@pennstatehealth.psu.edu.

Publikováno v: Addiction science & clinical practice [Addict Sci Clin Pract] 2024 Jul 27; Vol. 19 (1), pp. 56. Date of Electronic Publication: 2024 Jul 27.